Northern Trust’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Northern Trust’s Portfolio IMPL Stock Details IMPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,218	Closed	-$5.68K	–	4579
2023 Q3	$5.68K	Hold	13,218	–	–	﹤0.01%	4429
2023 Q2	$16.8K	Hold	13,218	–	–	﹤0.01%	4432
2023 Q1	$18.5K	Sell	13,218 -137	-1%	-$327	﹤0.01%	4461
2022 Q4	$50.1K	Hold	13,355	–	–	﹤0.01%	4287
2022 Q3	$65K	Buy	13,355 +3,135	+31%	+$24K	﹤0.01%	4251
2022 Q2	$95K	Sell	10,220 -39,765	-80%	-$291K	﹤0.01%	4192
2022 Q1	$318K	Buy	49,985 +663	+1%	+$5.01K	﹤0.01%	3927
2021 Q4	$426K	Sell	49,322 -1,212	-2%	-$12.1K	﹤0.01%	3869
2021 Q3	$615K	Sell	50,534 -7,959	-14%	-$116K	﹤0.01%	3690
2021 Q2	$518K	Buy	+58,493	New	+$698K	﹤0.01%	3692

Other funds holding IMPL

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Northern Trust's IMPL Position: Q4 2023 in Review

Northern Trust sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 13,218 shares — an estimated $5.68K sold.

Northern Trust first reported a position in IMPL in Q2 2021 and held it in 10 quarters. The position peaked at $615K in Q3 2021. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

Northern Trust reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Northern Trust sold 13,218 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $5.68K.
Northern Trust first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Northern Trust's Impel Pharmaceuticals Inc. Common Stock position peaked at $615K in Q3 2021.
2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.